Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies
about
Identification, characterization, and in vitro culture of highly divergent arenaviruses from boa constrictors and annulated tree boas: candidate etiological agents for snake inclusion body diseaseReporter-Expressing, Replicating-Competent Recombinant ArenavirusesSevere hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virusMembrane dynamics associated with viral infectionTwo-photon imaging of microbial immunity in living tissues.An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection.Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.LCMV glycosylation modulates viral fitness and cell tropism.The curious case of arenavirus entry, and its inhibition.Molecular mechanism of arenavirus assembly and budding.Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest.Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.Translational research in infectious disease: current paradigms and challenges ahead.Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth.Development of a minigenome system for Andes virus, a New World hantavirus.The search for animal models for Lassa fever vaccine developmentPathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.Arenavirus reverse genetics for vaccine developmentConstruction of a Sonchus Yellow Net Virus minireplicon: a step toward reverse genetic analysis of plant negative-strand RNA viruses.Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.Reverse Genetics Approaches to Control Arenavirus.A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress.Highlights in antiviral drug research: antivirals at the horizon.Host cell factors as antiviral targets in arenavirus infection.Current drug discovery strategies against arenavirus infections.Novel drug discovery approaches for treating arenavirus infections.Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.Vaccine platforms to control Lassa fever.Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.Lassa Virus Reverse Genetics.Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.Development of Recombinant Arenavirus-Based Vaccines.Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling
P2860
Q24617086-CC87F4C5-7789-4644-B933-5E3295DC4E53Q26742028-D85BA3FD-CE24-4E8D-9AB3-940DD069B9D7Q27305359-0C8F7627-99C4-4C61-B993-728AE72CFDA1Q28069980-2083058B-2C63-45F7-93F8-F0376BD2AD57Q30544651-71535B2B-0972-4DC4-B1B8-00AF30B5794EQ33875495-86F35D57-9992-43FA-9D03-480682852483Q34274569-49FFD307-EE4E-4B88-8E21-10F926C67E0DQ34544878-91120CE1-19E1-41A5-B4FF-8AB787EC435EQ34636037-4AE6867B-BE53-41AD-8AF6-AB81830532BDQ34645914-8C3BBEFB-8C0F-4A6A-B252-4143381A454BQ35140212-AE90AA31-3ABB-4052-B6C1-1C50585147A5Q35751585-B417326D-40A5-4008-A19C-5A2F970A0357Q35992621-5C69A5EF-A599-45C2-9FC9-B11BE6E4A86EQ36276510-3A827B01-699E-42F9-858D-CC3E02B8C51CQ36454591-389C6695-563A-4B34-8F97-EE6C53257BDAQ36588064-6FDC3C4F-62C6-49B6-8BB8-0C8964E9B81FQ36941000-719704A9-8008-496B-8AB4-63530488266DQ37006773-48041DEB-2848-494A-ACC5-30D9D5733264Q37252971-47D0E7D4-2D0D-4488-BB91-07F74E7B97E1Q37356067-82B3E81A-BFA8-4B90-AD15-A9DB839BB233Q37543755-75B40FF8-35D9-463F-8A1A-AEC64A9E19EDQ37714018-76F08A06-99D6-449C-BE01-7767F163B261Q38007145-453611A3-AD3E-4FFD-916C-54AE9F23E06AQ38061425-CB6A7B96-A0D2-407E-8CC3-CA7C253E4763Q38067504-CBA35ED9-DA98-470B-9432-4DD4BC892C71Q38735837-B84D6E85-68F2-4123-95AC-D00B489607E2Q38818648-29536EB3-9FC6-415D-AE82-81232C519924Q38823264-C88AA4E7-E731-4EB3-B490-F1AF111708A2Q39066377-EC32ED24-B759-4B9B-936E-74EAADDE7CE2Q40056797-A5FE7DC7-2EB5-4581-9AC7-EE8F7A676784Q40156113-50EBB6F6-B75A-4DDF-B678-E8194A1F4626Q40259618-77691118-E1EF-4854-AC01-142CA638FAE3Q42291845-ACE6E54F-F154-45F3-ABF6-9F7A9DC8011C
P2860
Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@ast
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@en
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@nl
type
label
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@ast
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@en
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@nl
prefLabel
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@ast
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@en
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@nl
P2093
P2860
P3181
P1433
P1476
Arenavirus reverse genetics: n ...... opment of antiviral strategies
@en
P2093
Juan C de la Torre
Sebastien E Emonet
Shuzo Urata
P2860
P304
P3181
P356
10.1016/J.VIROL.2011.01.013
P407
P577
2011-03-15T00:00:00Z